Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CELCNASDAQ:GRALNYSE:PACSNYSE:TDOC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCELCCelcuity$10.50-0.4%$10.19$7.58▼$19.77$397.59M0.56298,681 shs88,731 shsGRALGrail$41.09-3.0%$31.75$12.33▼$63.99$1.48BN/A1.26 million shs1.19 million shsPACSPACS Group$9.84-3.7%$10.03$8.28▼$43.92$1.50BN/A787,780 shs244,083 shsTDOCTeladoc Health$6.98-1.4%$7.34$6.35▼$15.21$1.22B1.826.24 million shs3.67 million shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCELCCelcuity-0.38%-0.94%-5.32%+10.53%-30.74%GRALGrail-2.95%+9.69%+11.36%+4.61%+4,108,999,900.00%PACSPACS Group-4.02%-0.68%+2.27%-24.41%-66.93%TDOCTeladoc Health-1.27%-0.07%-2.51%-26.01%-38.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCELCCelcuity2.1588 of 5 stars3.61.00.00.03.42.50.0GRALGrail0.4405 of 5 stars1.11.00.00.02.60.80.6PACSPACS Group3.7255 of 5 stars3.42.00.00.02.80.03.1TDOCTeladoc Health3.4372 of 5 stars4.22.00.00.02.82.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCELCCelcuity 3.17Buy$30.80193.33% UpsideGRALGrail 2.25Hold$31.50-23.34% DownsidePACSPACS Group 2.86Moderate Buy$34.29248.50% UpsideTDOCTeladoc Health 2.37Hold$9.6037.50% UpsideCurrent Analyst Ratings BreakdownLatest CELC, PACS, GRAL, and TDOC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025TDOCTeladoc HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$8.00 ➝ $7.005/27/2025TDOCTeladoc HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $9.005/19/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$27.00 ➝ $27.005/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.00 ➝ $29.005/14/2025GRALGrailCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$32.00 ➝ $43.005/8/2025TDOCTeladoc HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$10.00 ➝ $8.005/1/2025TDOCTeladoc HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $12.005/1/2025TDOCTeladoc HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$13.00 ➝ $10.005/1/2025TDOCTeladoc HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$9.00 ➝ $8.005/1/2025TDOCTeladoc HealthEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$8.00 ➝ $7.005/1/2025TDOCTeladoc HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCELCCelcuityN/AN/AN/AN/A$5.48 per shareN/AGRALGrail$130.71M11.31N/AN/AN/A∞PACSPACS Group$3.56B0.42N/AN/AN/A∞TDOCTeladoc Health$2.55B0.48$0.45 per share15.64$14.05 per share0.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCELCCelcuity-$63.78M-$3.03N/AN/AN/AN/A-62.66%-39.78%8/13/2025 (Estimated)GRALGrailN/A-$60.99N/AN/AN/AN/AN/AN/A8/12/2025 (Estimated)PACSPACS Group$112.87MN/A0.005.530.49N/AN/AN/AN/ATDOCTeladoc Health-$220.37M-$5.92N/AN/AN/A-37.91%-10.06%-4.86%7/30/2025 (Estimated)Latest CELC, PACS, GRAL, and TDOC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025CELCCelcuity-$0.95-$0.86+$0.09-$0.86N/AN/A5/13/2025Q1 2025GRALGrail-$4.03-$3.10+$0.93-$3.10$35.80 million$31.84 million3/31/2025Q4 2024CELCCelcuity-$0.72-$0.85-$0.13-$0.85N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCELCCelcuityN/AN/AN/AN/AN/AGRALGrailN/AN/AN/AN/AN/APACSPACS GroupN/AN/AN/AN/AN/ATDOCTeladoc HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCELCCelcuity0.6510.3510.36GRALGrailN/A9.659.65PACSPACS Group0.821.711.71TDOCTeladoc Health0.661.731.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCELCCelcuity63.33%GRALGrailN/APACSPACS GroupN/ATDOCTeladoc Health76.82%Insider OwnershipCompanyInsider OwnershipCELCCelcuity15.78%GRALGrail1.85%PACSPACS GroupN/ATDOCTeladoc Health0.58%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCELCCelcuity4037.87 million31.27 millionOptionableGRALGrail1,36035.97 millionN/AOptionablePACSPACS Group32,433152.40 millionN/AOptionableTDOCTeladoc Health5,100175.44 million170.53 millionOptionableCELC, PACS, GRAL, and TDOC HeadlinesRecent News About These CompaniesTeladoc Health (NYSE:TDOC) Price Target Cut to $9.00 by Analysts at Truist FinancialMay 29 at 1:53 AM | americanbankingnews.comTruist Financial Lowers Teladoc Health (NYSE:TDOC) Price Target to $9.00May 28 at 11:51 AM | marketbeat.comVoloridge Investment Management LLC Sells 675,053 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 26 at 4:45 AM | marketbeat.comNuveen Asset Management LLC Sells 3,954,272 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 26 at 3:54 AM | marketbeat.comDeutsche Bank AG Has $1.56 Million Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)May 26 at 3:34 AM | marketbeat.com2,018,508 Shares in Teladoc Health, Inc. (NYSE:TDOC) Purchased by Two Sigma Investments LPMay 25, 2025 | marketbeat.com1 Russell 2000 Stock for Long-Term Investors and 2 to Be Wary OfMay 23, 2025 | finance.yahoo.comTwinbeech Capital LP Increases Holdings in Teladoc Health, Inc. (NYSE:TDOC)May 23, 2025 | marketbeat.comTwo Sigma Advisers LP Has $20.53 Million Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)May 23, 2025 | marketbeat.comTeza Capital Management LLC Sells 89,993 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 22, 2025 | marketbeat.comTeladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Quantinno Capital Management LPMay 22, 2025 | marketbeat.comTeladoc Health, Inc. (NYSE:TDOC) Shares Sold by Man Group plcMay 22, 2025 | marketbeat.comCresset Asset Management LLC Sells 83,430 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 21, 2025 | marketbeat.comAmeriprise Financial Inc. Lowers Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)May 21, 2025 | marketbeat.comAnalysts Offer Predictions for Teladoc Health Q2 EarningsMay 20, 2025 | americanbankingnews.comZacks Research Expects Stronger Earnings for Teladoc HealthMay 20, 2025 | marketbeat.comTeladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Point72 Asset Management L.P.May 17, 2025 | marketbeat.comNorthern Trust Corp Acquires 161,875 Shares of Teladoc Health, Inc. (NYSE:TDOC)May 17, 2025 | marketbeat.comTeladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin PressureMay 16, 2025 | benzinga.comMoore Capital Management LP Buys Shares of 178,461 Teladoc Health, Inc. (NYSE:TDOC)May 15, 2025 | marketbeat.comAlgert Global LLC Invests $313,000 in Teladoc Health, Inc. (NYSE:TDOC)May 15, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCELC, PACS, GRAL, and TDOC Company DescriptionsCelcuity NASDAQ:CELC$10.50 -0.04 (-0.38%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$10.52 +0.02 (+0.19%) As of 05/28/2025 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.Grail NASDAQ:GRAL$41.09 -1.25 (-2.95%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$42.39 +1.30 (+3.16%) As of 05/28/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.PACS Group NYSE:PACS$9.84 -0.38 (-3.74%) Closing price 05/28/2025 03:59 PM EasternExtended Trading$9.80 -0.04 (-0.39%) As of 05/28/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.Teladoc Health NYSE:TDOC$6.98 -0.10 (-1.41%) Closing price 05/28/2025 03:59 PM EasternExtended Trading$7.06 +0.07 (+1.07%) As of 05/28/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
